Jacob Lønborg1*, MD, PhD; Henning Kelbæk1, MD, DMSc; Thomas Engstrøm1, MD, PhD, DMSc; Steffen Helqvist1, MD, DMSc; Lene Kløvgaard1, RN; Lene Holmvang1, MD, DMSc; Niels Vejlstrup1, MD, PhD; Erik Jørgensen1, MD; Kari Saunamäki1, MD, DMSc; Nadia P. Dridi1, MD; Anne Kaltoft2, MD; Hans-Erik Bøtker2, MD, DMSc; Peter Clemmensen1, MD, DMSc; Christian Juhl Terkelsen2, MD, PhD, DMSc
1. Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 2. Department of Cardiology, Skejby, University of Aarhus, Aarhus, Denmark
Aims: To evaluate the clinical importance of the ST peak phenomenon during primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (ST